| Field | Specification |
|---|---|
| Gene ID | |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Applications | |
| Conjugate | |
| Concentration | |
| Storage | |
| Storage buffer | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.
Validated Applications & Recommended Dilutions
| Application | Recommended Dilution |
|---|---|
| Flow Cytometry | See product datasheet |
Antibody Specifications
| Target | F4/80 |
|---|---|
| Host Species | Rat |
| Clonality | Monoclonal |
| Isotype | Rat IgG2b, κ |
| Conjugate | FITC |
| Clone Number | CI:A3-1 |
| Purification | See datasheet |
| Concentration | 0.5 mg/mL |
Immunogen
Recombinant protein fragment; see full datasheet. UniProt: Q61549.
Species Reactivity & Cross-Reactivity
Validated for: Mouse. Verify suitability in your sample type prior to use. For species or applications not listed in the datasheet, consult our technical team before purchase.
Storage & Handling
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Related Products
Browse additional antibodies targeting F4/80 and complementary reagents — including secondary antibodies, blocking buffers, and detection kits — available through BioHippo.
This antibody is validated for flow cytometry applications. For intracellular targets, fix and permeabilize cells using a validated fixation/permeabilization kit (e.g., BD Cytofix/Cytoperm or similar) before staining. For surface markers, stain live or fixed cells without permeabilization. Always include a matched isotype control (Rat IgG2b, κ, Rat origin) at the same protein concentration as the test antibody to establish non-specific binding thresholds. Recommended starting dilution/concentration: see datasheet.
This antibody has been experimentally validated in: Mouse. Cross-reactivity with other species has not been systematically evaluated. If your sample species is not listed, assess immunogen sequence homology to your target species ortholog. The immunogen used is: "" — higher sequence identity between species increases the probability of cross-reactivity, but experimental validation with appropriate controls is necessary before drawing scientific conclusions.
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.. To maintain antibody activity, avoid repeated freeze-thaw cycles. Aliquot into single-use volumes before first freeze. If working with the antibody frequently, keep a working stock at 4°C for up to 4 weeks — add 0.02% sodium azide to the working stock as a bacteriostatic agent if azide is not already present in the buffer. Monitor performance against a validated positive control when transitioning between storage aliquots or lots.
This monoclonal antibody (clone CI:A3-1) provides highly consistent, epitope-specific recognition of F4/80, making it ideal for quantitative assays, multiplex panels, and studies requiring strict reproducibility across experiments and independent laboratories. Unlike polyclonal preparations, each production batch from a single hybridoma clone generates antibody with identical epitope specificity, affinity, and isotype — ensuring reliable signal comparison in longitudinal studies or multi-site collaborations. When citing this antibody in publications, include the clone designation (clone CI:A3-1) to enable third-party reproducibility verification.
Customization & Add-ons: Can't find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
“Triple-Hop” nano-bomb combining CDT, PDT and immunetherapy for NIR-triggered cancer therapy (2023) CHEMICAL ENGINEERING JOURNAL. 10.1016/j.cej.2023.148268
A pH-Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury (2025) Advanced Science. 10.1002/advs.202515664
PD1 cell membrane-coated Ru(ll)-Pt(lV) complex nanoparticles inhibit liver metastatic melanoma via cascade immune activation (2026) JOURNAL OF NANOBIOTECHNOLOGY. 10.1186/s12951-026-04167-x
Dual-functional Self-assembled Nanosystems with Enhanced Protease Resistance: Promoting Bacterial Aggregation and Immune Activation for Multidrug-resistant Bacterial Infection (2026) Asian Journal of Pharmaceutical Sciences. 10.1016/j.ajps.2026.101145
Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer (2025) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 10.1186/s13046-025-03282-1
Synergetic regulation of osteoimmune microenvironment and osteogenesis by decellularized amnion membrane for guided bone regeneration (2025) Materials Today Bio. 10.1016/j.mtbio.2025.102640
Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping (2024) Acta Biomaterialia. 10.1016/j.actbio.2024.12.048
Transcutaneous allicin oleogel restores energy homeostasis for obesity treatment (2026) ACTA PHARMACOLOGICA SINICA. 10.1038/s41401-026-01768-y
Host Defense Peptide Mimics Synergize with Pt(IV) Prodrugs for Surmounting Cisplatin Resistance via Selective Cancer Membrane Disruption (2025) ACS Applied Materials & Interfaces. 10.1021/acsami.4c21448
Diosgenin ameliorates colitis by inhibiting mitochondrial DNA synthesis in macrophages via STAT2-CMPK2 pathway (2025) PHYTOMEDICINE. 10.1016/j.phymed.2025.157605
Development strategies for sorafenib-based targeted radiotheranostic biomaterials: From targeted delivery to multimodal monitoring (2026) Materials Today Nano. 10.1016/j.mtnano.2026.100762
Drug Repurposing with Topical Paclitaxel Delivery for Psoriasis Treatment Enabled by Plant-Inspired Molecular Assembly (2025) ACS Applied Materials & Interfaces. 10.1021/acsami.5c08843
ILF2 cooperates with ILF3/KLF16 to drive colorectal cancer progression via modulating the behaviors of both tumor cells and M2 macrophages (2026) APOPTOSIS. 10.1007/s10495-026-02259-5
Microcystin-LR Impairs Endometrial Receptivity during the Peri-Implantation Window via Disruption of STAT3/HIF-1α Signaling (2025) Environment & Health. 10.1021/envhealth.5c00352
Schistosoma japonicum-derived peptide SJMHE1 ameliorates allergic symptoms and responses in mice with allergic rhinitis (2023) Frontiers in Cellular and Infection Microbiology. 10.3389/fcimb.2023.1143950
Fucoxanthin prevents septic cardiomyopathy by targeting BRD2 in M1-polarized macrophages (2025) Food & Function. 10.1039/D5FO04244E
Enhancing Tumor-Specific immunity with SLdacA: A attenuated Salmonella-mediated c-di-AMP delivery system targeting the STING pathway (2024) INTERNATIONAL JOURNAL OF PHARMACEUTICS. 10.1016/j.ijpharm.2024.124759
Attenuated mutants of Salmonella enterica Typhimurium mediate melanoma regression via an immune response (2024) EXPERIMENTAL BIOLOGY AND MEDICINE. 10.3389/ebm.2024.10081
Ajania purpurea Extract Attenuates LPS-Induced Inflammation in RAW264.7 Cells and Peritonitis Mice (2022) BIOLOGICAL & PHARMACEUTICAL BULLETIN. 10.1248/bpb.b22-00388
Yinxie I Formula attenuates imiquimod-induced psoriasis-like skin inflammation via IL-23/IL-17 axis (2024) ARCHIVES OF DERMATOLOGICAL RESEARCH. 10.1007/s00403-024-03288-3
